Inhibition of mitochondrial translocator protein prevents atrial fibrillation

European Journal of Pharmacology

Volumn 632, Issue 1-3, 2010, Pages 60-64

  Li, Jun ^a,b,c   Xiao, Junjie ^a,b,c   Liang, Dandan ^a,b,c   Zhang, Hong ^a,c   Zhang, Gaofeng ^c   Liu, Yi ^b,c   Zhang, Yangyang ^d   Liu, Ying ^c   Yu, Zhuo ^e   Yan, Biao ^c   Jiang, Bing ^b   Li, Fei ^b   Peng, Luying ^b,c   Zhou, Zhao Nian ^e   Chen, Yi Han ^a,b,c  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c TONGJI UNIVERSITY   (China)

^d NANJING MEDICAL UNIVERSITY   (China)

^e Chinese Academy of Sciences   (China)

Author keywords

Atrial fibrillation; Ca2+ overload; Mitochondria

Indexed keywords

4' CHLORODIAZEPAM; ADENOSINE TRIPHOSPHATE; CALCIUM ION; CARRIER PROTEIN; FURA 2; FURA 2 ACETOXYMETHYL ESTER; MAGNESIUM FURA 2; MITOCHONDRIAL TRANSLOCATOR PROTEIN; UNCLASSIFIED DRUG;

AGITATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM CHANNELOPATHY; CALCIUM OVERLOAD; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; DRUG ACTIVITY; ENERGY METABOLISM; HEART ATRIUM FIBRILLATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RISK REDUCTION;

ANIMALS; ATRIAL FIBRILLATION; CELL LINE; FLUORESCENT DYES; FURA-2; HEART; HEART ATRIA; HEART FAILURE; MITOCHONDRIAL PROTEINS; MODELS, CARDIOVASCULAR; RABBITS; RANDOM ALLOCATION;

EID: 77349102197     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.01.014     Document Type: Article

References (24)

1. Ad N., Schneider A., Khaliulin I., Borman J.B., and Schwalb H. Impaired mitochondrial response to simulated ischemic injury as a predictor of the development of atrial fibrillation after cardiac surgery: in vitro study in human myocardium. J. Thorac. Cardiovasc. Surg. 129 (2005) 41-45
2. Akar F.G., Aon M.A., Tomaselli G.F., and O'Rourke B. The mitochondrial origin of postischemic arrhythmias. J. Clin. Invest. 115 (2005) 3527-3535
3. Ausma J., Coumans W.A., Duimel H., Van der Vusse G.J., Allessie M.A., and Borgers M. Atrial high energy phosphate content and mitochondrial enzyme activity during chronic atrial fibrillation. Cardiovasc. Res. 47 (2000) 788-796
4. Brown D.A., Aon M.A., Akar F.G., Liu T., Sorarrain N., and O'Rourke B. Effects of 4′-chlorodiazepam on cellular excitation-contraction coupling and ischaemia reperfusion injury in rabbit heart. Cardiovasc. Res. 79 (2008) 141-149
5. Chou C.C., Nihei M., Zhou S., Tan A., Kawase A., Macias E.S., Fishbein M.C., Lin S.F., and Chen P.S. Intracellular calcium dynamics and anisotropic reentry in isolated canine pulmonary veins and left atrium. Circulation 111 (2005) 2889-2897
6. Claycomb W.C., Lanson N.A., Stallworth B.S., Egeland D.B., Delcarpio J.B., Bahinski A., and Izzo N.J. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 2979-2984
7. Di Lisa F., Blank P.S., Colonna R., Gambassi G., Silverman H.S., Stern M.D., and Hansford R.G. Mitochondrial membrane potential in single living adult rat cardiac myocytes exposed to anoxia or metabolic inhibition. J. Physiol. 486 (1995) 1-13
8. 2+ channels a promising approach to prevent electrical remodeling and arrhythmogenesis?. Naunyn. Schmiedebergs. Arch. Pharmacol. 376 (2007) 227-230
9. Gavish M., Bachman I., Shoukrun R., Katz Y., Veenman L., Weisinger G., and Weizman A. Enigma of the peripheral benzodiazepine receptor. Pharmacol. Rev. 51 (1999) 629-650
10. Goette A., Honeycutt C., and Langberg J.J. Electrical remodeling in atrial fibrillation: time course and mechanisms. Circulation 94 (1996) 2968-2974
11. Gustafsson A.B., and Gottlieb R.A. Heart mitochondria: gates of life and death. Cardiovasc. Res. 77 (2008) 334-343
12. Iqbal M.B., Taneja A.K., Lip G.Y.H., and Flather M. Recent developments in atrial fibrillation. BMJ 330 (2005) 238-243
13. Kalifa J., Maixent J.M., Chalvidan T., Dalmasso C., Colin D., Cozma D., Laurent P., Deharo J.C., Djiane P., Cozzone P., and Bernard M. Energetic metabolism during acute stretch-related atrial fibrillation. Mol. Cell Biochem. 317 (2008) 69-75
14. Khairy P., and Nattel S. New insights into the mechanisms and management of atrial fibrillation. CMAJ 167 (2002) 1012-1020
15. Kondrat'ev B.Y., Ugdyzhekova D.S., Antonchenko I.V., Aleev V.V., Popov S.V., and Afanas'ev S.A. Metabolic alterations in rat myocardium in experimental acute atrial fibrillation. Bull. Exp. Biol. Med. 140 (2005) 397-399
16. Mihm M.J., Yu F., Carnes C.A., Reiser P.J., McCarthy P.M., Van Wagoner D.R., and Bauer J.A. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 104 (2001) 174-180
17. 2+ exchange in isolated guinea-pig cardiac myocytes. J. Mol. Cell. Cardiol. 29 (1997) 2979-2987
18. Moe G.K., and Abildskov J.A. Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. Am. Heart J. 58 (1959) 59-70
19. Papadopoulos V., Baraldi M., Guilarte T.R., Knudsen T.B., Lacapere J.J., Lindemann P., Norenberg M.D., Nutt D., Weizman A., Zhang M.R., and Gavish M. Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol. Sci. 27 (2006) 402-409
20. Rosenberg P. Mitochondrial dysfunction and heart disease. Mitochondrion. 4 (2004) 5-6
21. + exchanger. Am. J. Physiol. Heart Circ. Physiol. 291 (2006) H2790-800
22. Sharifov O.F., Fedorov V.V., Beloshapko G.G., Glukhov A.V., Yushmanova A.V., and Rosenshtraukh L.V. Roles of adrenergic and cholinergic stimulation in spontaneous atrial fibrillation in dogs. J. Am. Coll. Cardiol. 43 (2004) 483-490
23. Veenhuyzen G.D., Simpson C.S., and Abdollah H. Atrial fibrillation. CMAJ 171 (2004) 755-760
24. Veenman L., and Gavish M. The peripheral-type benzodiazepine receptor and the cardiovascular system. Implications for drug development. Pharmacol. Ther. 110 (2006) 503-524